{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T20:29:19Z","timestamp":1778790559598,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Ministry of Innovation and Technology of Hungary from the National Research, Development and Innovation Fund","award":["TKP2021-EGA-24 (MOLORKIV)"],"award-info":[{"award-number":["TKP2021-EGA-24 (MOLORKIV)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-20926-6","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:15:12Z","timestamp":1761128112000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["In vitro complement activation via nucleocapsid and spike proteins of SARS-CoV-2 in COVID-19 patients"],"prefix":"10.1038","volume":"15","author":[{"given":"Petra","family":"Kiszel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e1nos","family":"Mikl\u00f3s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Kajd\u00e1csi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gy\u00f6rgy","family":"Sinkovits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"Cervenak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zolt\u00e1n","family":"Proh\u00e1szka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"20926_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41590-021-01091-0","volume":"23","author":"MS Diamond","year":"2022","unstructured":"Diamond, M. S. & Kanneganti, T. D. Innate immunity: the first line of defense against SARS-CoV-2. Nat. Immunol. 23, 165\u2013176. https:\/\/doi.org\/10.1038\/s41590-021-01091-0 (2022).","journal-title":"Nat. Immunol."},{"key":"20926_CR2","doi-asserted-by":"publisher","unstructured":"Jayaraman, A., Walachowski, S. & Bosmann, M. The complement system: A key player in the host response to infections. Eur. J. Immunol. e2350814 https:\/\/doi.org\/10.1002\/eji.202350814 (2024).","DOI":"10.1002\/eji.202350814"},{"key":"20926_CR3","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s00018-024-05157-8","volume":"81","author":"MT Xiao","year":"2024","unstructured":"Xiao, M. T., Ellsworth, C. R. & Qin, X. Emerging role of complement in COVID-19 and other respiratory virus diseases. Cell. Mol. Life Sci. 81, 94. https:\/\/doi.org\/10.1007\/s00018-024-05157-8 (2024).","journal-title":"Cell. Mol. Life Sci."},{"key":"20926_CR4","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/imcb.12324","volume":"98","author":"BS Goldberg","year":"2020","unstructured":"Goldberg, B. S. & Ackerman, M. E. Antibody-mediated complement activation in pathology and protection. Immunol. Cell. Biol. 98, 305\u2013317. https:\/\/doi.org\/10.1111\/imcb.12324 (2020).","journal-title":"Immunol. Cell. Biol."},{"key":"20926_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41579-022-00713-0","volume":"20","author":"MM Lamers","year":"2022","unstructured":"Lamers, M. M. & Haagmans, B. L. SARS-CoV-2 pathogenesis. Nat. Rev. Microbiol. 20, 270\u2013284. https:\/\/doi.org\/10.1038\/s41579-022-00713-0 (2022).","journal-title":"Nat. Rev. Microbiol."},{"key":"20926_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41577-021-00665-1","volume":"22","author":"B Afzali","year":"2022","unstructured":"Afzali, B., Noris, M., Lambrecht, B. N. & Kemper, C. The state of complement in COVID-19. Nat. Rev. Immunol. 22, 77\u201384. https:\/\/doi.org\/10.1038\/s41577-021-00665-1 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"20926_CR7","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.chom.2021.06.009","volume":"29","author":"K Roltgen","year":"2021","unstructured":"Roltgen, K. & Boyd, S. D. Antibody and B cell responses to SARS-CoV-2 infection and vaccination. Cell. Host Microbe. 29, 1063\u20131075. https:\/\/doi.org\/10.1016\/j.chom.2021.06.009 (2021).","journal-title":"Cell. Host Microbe"},{"key":"20926_CR8","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev-pathmechdis-031521-042754","volume":"19","author":"K Roltgen","year":"2024","unstructured":"Roltgen, K., Boyd, S. D. & Antibody Cell responses to SARS-CoV-2 infection and vaccination: the end of the beginning. Annu. Rev. Pathol. 19, 69\u201397. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-031521-042754 (2024).","journal-title":"Annu. Rev. Pathol."},{"key":"20926_CR9","doi-asserted-by":"publisher","unstructured":"Larsen, M. D. et al. Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity. Science 371 https:\/\/doi.org\/10.1126\/science.abc8378 (2021).","DOI":"10.1126\/science.abc8378"},{"key":"20926_CR10","doi-asserted-by":"publisher","unstructured":"Zohar, T. et al. Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality. Cell 183, 1508\u20131519 e1512, (2020). https:\/\/doi.org\/10.1016\/j.cell.2020.10.052","DOI":"10.1016\/j.cell.2020.10.052"},{"key":"20926_CR11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.cmi.2021.10.005","volume":"28","author":"T Fiolet","year":"2022","unstructured":"Fiolet, T., Kherabi, Y., MacDonald, C. J. & Ghosn, J. Peiffer-Smadja, N. Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review. Clin. Microbiol. Infect. 28, 202\u2013221. https:\/\/doi.org\/10.1016\/j.cmi.2021.10.005 (2022).","journal-title":"Clin. Microbiol. Infect."},{"key":"20926_CR12","doi-asserted-by":"publisher","first-page":"632814","DOI":"10.3389\/fimmu.2021.632814","volume":"12","author":"H Luo","year":"2021","unstructured":"Luo, H. et al. The characterization of disease severity associated IgG subclasses response in COVID-19 patients. Front. Immunol. 12, 632814. https:\/\/doi.org\/10.3389\/fimmu.2021.632814 (2021).","journal-title":"Front. Immunol."},{"key":"20926_CR13","doi-asserted-by":"publisher","first-page":"100329","DOI":"10.1016\/j.xcrm.2021.100329","volume":"2","author":"JL Yates","year":"2021","unstructured":"Yates, J. L. et al. Serological analysis reveals an imbalanced IgG subclass composition associated with COVID-19 disease severity. Cell. Rep. Med. 2, 100329. https:\/\/doi.org\/10.1016\/j.xcrm.2021.100329 (2021).","journal-title":"Cell. Rep. Med."},{"key":"20926_CR14","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.4049\/jimmunol.2300307","volume":"211","author":"T Damelang","year":"2023","unstructured":"Damelang, T. et al. The influence of human IgG subclass and allotype on complement activation. J. Immunol. 211, 1725\u20131735. https:\/\/doi.org\/10.4049\/jimmunol.2300307 (2023).","journal-title":"J. Immunol."},{"key":"20926_CR15","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.4049\/jimmunol.1600863","volume":"197","author":"BL Garcia","year":"2016","unstructured":"Garcia, B. L., Zwarthoff, S. A., Rooijakkers, S. H. & Geisbrecht, B. V. Novel evasion mechanisms of the classical complement pathway. J. Immunol. 197, 2051\u20132060. https:\/\/doi.org\/10.4049\/jimmunol.1600863 (2016).","journal-title":"J. Immunol."},{"key":"20926_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.it.2020.12.002","volume":"42","author":"L Kurtovic","year":"2021","unstructured":"Kurtovic, L. & Beeson, J. G. Complement factors in COVID-19 therapeutics and vaccines. Trends Immunol. 42, 94\u2013103. https:\/\/doi.org\/10.1016\/j.it.2020.12.002 (2021).","journal-title":"Trends Immunol."},{"key":"20926_CR17","doi-asserted-by":"publisher","first-page":"838780","DOI":"10.3389\/fimmu.2022.838780","volume":"13","author":"RE Lamerton","year":"2022","unstructured":"Lamerton, R. E. et al. SARS-CoV-2 Spike- and Nucleoprotein-Specific antibodies induced after vaccination or infection promote classical complement activation. Front. Immunol. 13, 838780. https:\/\/doi.org\/10.3389\/fimmu.2022.838780 (2022).","journal-title":"Front. Immunol."},{"key":"20926_CR18","doi-asserted-by":"publisher","first-page":"663187","DOI":"10.3389\/fimmu.2021.663187","volume":"12","author":"G Sinkovits","year":"2021","unstructured":"Sinkovits, G. et al. Complement overactivation and consumption predicts In-Hospital mortality in SARS-CoV-2 infection. Front. Immunol. 12, 663187. https:\/\/doi.org\/10.3389\/fimmu.2021.663187 (2021).","journal-title":"Front. Immunol."},{"key":"20926_CR19","doi-asserted-by":"publisher","first-page":"1039765","DOI":"10.3389\/fimmu.2022.1039765","volume":"13","author":"L Hurler","year":"2022","unstructured":"Hurler, L. et al. Distinction of early complement classical and lectin pathway activation via quantification of C1s\/C1-INH and MASP-1\/C1-INH complexes using novel ELISAs. Front. Immunol. 13, 1039765. https:\/\/doi.org\/10.3389\/fimmu.2022.1039765 (2022).","journal-title":"Front. Immunol."},{"key":"20926_CR20","doi-asserted-by":"publisher","first-page":"1162171","DOI":"10.3389\/fimmu.2023.1162171","volume":"14","author":"L Hurler","year":"2023","unstructured":"Hurler, L. et al. Complement lectin pathway activation is associated with COVID-19 disease severity, independent of MBL2 genotype subgroups. Front. Immunol. 14, 1162171. https:\/\/doi.org\/10.3389\/fimmu.2023.1162171 (2023).","journal-title":"Front. Immunol."},{"key":"20926_CR21","doi-asserted-by":"publisher","first-page":"19759","DOI":"10.1038\/s41598-022-23806-5","volume":"12","author":"G Sinkovits","year":"2022","unstructured":"Sinkovits, G. et al. Evidence, detailed characterization and clinical context of complement activation in acute multisystem inflammatory syndrome in children. Sci. Rep. 12, 19759. https:\/\/doi.org\/10.1038\/s41598-022-23806-5 (2022).","journal-title":"Sci. Rep."},{"key":"20926_CR22","doi-asserted-by":"publisher","first-page":"13166","DOI":"10.1038\/s41598-023-40103-x","volume":"13","author":"P Kiszel","year":"2023","unstructured":"Kiszel, P. et al. Class switch towards Spike protein-specific IgG4 antibodies after SARS-CoV-2 mRNA vaccination depends on prior infection history. Sci. Rep. 13, 13166. https:\/\/doi.org\/10.1038\/s41598-023-40103-x (2023).","journal-title":"Sci. Rep."},{"key":"20926_CR23","doi-asserted-by":"publisher","first-page":"25018","DOI":"10.1073\/pnas.2010540117","volume":"117","author":"JC Holter","year":"2020","unstructured":"Holter, J. C. et al. Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients. Proc. Natl. Acad. Sci. U S A. 117, 25018\u201325025. https:\/\/doi.org\/10.1073\/pnas.2010540117 (2020).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"20926_CR24","doi-asserted-by":"publisher","first-page":"e28122","DOI":"10.1002\/jmv.28122","volume":"95","author":"M Arish","year":"2023","unstructured":"Arish, M., Qian, W., Narasimhan, H. & Sun, J. COVID-19 immunopathology: from acute diseases to chronic sequelae. J. Med. Virol. 95, e28122. https:\/\/doi.org\/10.1002\/jmv.28122 (2023).","journal-title":"J. Med. Virol."},{"key":"20926_CR25","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","volume":"5","author":"G Vidarsson","year":"2014","unstructured":"Vidarsson, G., Dekkers, G. & Rispens, T. IgG subclasses and allotypes: from structure to effector functions. Front. Immunol. 5, 520. https:\/\/doi.org\/10.3389\/fimmu.2014.00520 (2014).","journal-title":"Front. Immunol."},{"key":"20926_CR26","doi-asserted-by":"publisher","first-page":"4160","DOI":"10.1172\/JCI82695","volume":"125","author":"I Quast","year":"2015","unstructured":"Quast, I. et al. Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity. J. Clin. Invest. 125, 4160\u20134170. https:\/\/doi.org\/10.1172\/JCI82695 (2015).","journal-title":"J. Clin. Invest."},{"key":"20926_CR27","doi-asserted-by":"publisher","unstructured":"Kocsis, A. et al. SARS-CoV-2 nucleocapsid protein is not responsible for Over-Activation of complement lectin pathway. Int. J. Mol. Sci. 25 https:\/\/doi.org\/10.3390\/ijms25137343 (2024).","DOI":"10.3390\/ijms25137343"},{"key":"20926_CR28","doi-asserted-by":"publisher","first-page":"1419165","DOI":"10.3389\/fimmu.2024.1419165","volume":"15","author":"I Bally","year":"2024","unstructured":"Bally, I. et al. Revisiting the interaction between complement lectin pathway protease MASP-2 and SARS-CoV-2 nucleoprotein. Front. Immunol. 15, 1419165. https:\/\/doi.org\/10.3389\/fimmu.2024.1419165 (2024).","journal-title":"Front. Immunol."},{"key":"20926_CR29","doi-asserted-by":"publisher","unstructured":"Ma, L. et al. Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection. Sci. Immunol. 6 https:\/\/doi.org\/10.1126\/sciimmunol.abh2259 (2021).","DOI":"10.1126\/sciimmunol.abh2259"},{"key":"20926_CR30","doi-asserted-by":"publisher","unstructured":"Boussier, J. et al. Severe COVID-19 is associated with hyperactivation of the alternative complement pathway. J Allergy Clin Immunol 149, 550\u2013556 e552, (2022). https:\/\/doi.org\/10.1016\/j.jaci.2021.11.004","DOI":"10.1016\/j.jaci.2021.11.004"},{"key":"20926_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00430-021-00725-2","volume":"211","author":"A Leatherdale","year":"2022","unstructured":"Leatherdale, A. et al. Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality. Med. Microbiol. Immunol. 211, 37\u201348. https:\/\/doi.org\/10.1007\/s00430-021-00725-2 (2022).","journal-title":"Med. Microbiol. Immunol."},{"key":"20926_CR32","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/imm.13585","volume":"168","author":"MK Siggins","year":"2023","unstructured":"Siggins, M. K. et al. Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID-19. Immunology 168, 473\u2013492. https:\/\/doi.org\/10.1111\/imm.13585 (2023).","journal-title":"Immunology"},{"key":"20926_CR33","doi-asserted-by":"publisher","first-page":"767981","DOI":"10.3389\/fimmu.2021.767981","volume":"12","author":"I Jarlhelt","year":"2021","unstructured":"Jarlhelt, I. et al. SARS-CoV-2 antibodies mediate complement and cellular driven inflammation. Front. Immunol. 12, 767981. https:\/\/doi.org\/10.3389\/fimmu.2021.767981 (2021).","journal-title":"Front. Immunol."},{"key":"20926_CR34","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1093\/infdis\/jiac091","volume":"226","author":"PMS Castanha","year":"2022","unstructured":"Castanha, P. M. S. et al. Contribution of coronavirus-Specific Immunoglobulin G responses to complement overactivation in patients with severe coronavirus disease 2019. J. Infect. Dis. 226, 766\u2013777. https:\/\/doi.org\/10.1093\/infdis\/jiac091 (2022).","journal-title":"J. Infect. Dis."},{"key":"20926_CR35","doi-asserted-by":"publisher","first-page":"eabp9770","DOI":"10.1126\/sciadv.abp9770","volume":"8","author":"AD Lopez-Munoz","year":"2022","unstructured":"Lopez-Munoz, A. D., Kosik, I., Holly, J. & Yewdell, J. W. Cell surface SARS-CoV-2 nucleocapsid protein modulates innate and adaptive immunity. Sci. Adv. 8, eabp9770. https:\/\/doi.org\/10.1126\/sciadv.abp9770 (2022).","journal-title":"Sci. Adv."},{"key":"20926_CR36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0022-1759(88)90160-3","volume":"114","author":"C Delamarche","year":"1988","unstructured":"Delamarche, C., Berger, F., Pouplard, A. & Emile, J. An ELISA technique for the measurement of C1q in cerebrospinal fluid. J. Immunol. Methods. 114, 101\u2013106. https:\/\/doi.org\/10.1016\/0022-1759(88)90160-3 (1988).","journal-title":"J. Immunol. Methods"},{"key":"20926_CR37","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1111\/j.1538-7836.2012.04674.x","volume":"10","author":"M Reti","year":"2012","unstructured":"Reti, M. et al. Complement activation in thrombotic thrombocytopenic purpura. J. Thromb. Haemost. 10, 791\u2013798. https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04674.x (2012).","journal-title":"J. Thromb. Haemost"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20926-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20926-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20926-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:15:14Z","timestamp":1761128114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20926-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20926"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20926-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36951"}}